mGlu 4 allosteric modulation for treating Parkinson's disease

Title
mGlu 4 allosteric modulation for treating Parkinson's disease
Authors
Keywords
Parkinson's disease, Dyskinesia, Glutamate, Dopamine, mGlu, 4
Journal
NEUROPHARMACOLOGY
Volume 135, Issue -, Pages 308-315
Publisher
Elsevier BV
Online
2018-03-24
DOI
10.1016/j.neuropharm.2018.03.027

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started